Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19

he role of corticosteroids in treating severe infections has been an enduring controversy. During the coronavirus disease 2019 (COVID-19) pandemic, rigorous data on the efficacy of corticosteroids have been limited. The pandemic has been a potent stimulus for clinical research addressing this controversy. The objective of this prospective meta-analysis of randomized trials was to estimate the association between administration of corticosteroids, compared with usual care or placebo, and 28-day all-cause mortality in hospitalized, critically ill patients with suspected or confirmed COVID-19.

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19
Size: 571 KB